Eli Lilly at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Eli Lilly takes part in 2 sessions at BioTechX Europe 2026 in Basel. Its sessions cover AI in clinical research, from genetic analysis to how new AI tools get adopted. Topics include using AI to study rare genetic variants in neurodegenerative disease in UK Biobank and trial data, and why managing organisational change must be built into clinical AI projects from the start.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company developing and marketing medicines in areas including diabetes, obesity, oncology, immunology and neuroscience. | Talk Tue Oct 6 16:10 Talk Wed Oct 7 11:45 Designed In, Not Bolted On: Why Change Management Is the Missing Infrastructure in Clinical AI Deployments Why clinical trial AI tools stall with the teams meant to use them, and how to plan for adoption from day one. |
Instantly find 20 buyers from Eli Lilly
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction